Evaluating ChatGPT-4o as a decision support tool in multidisciplinary sarcoma tumor boards: heterogeneous performance across various specialties.

Journal: Frontiers in oncology
Published Date:

Abstract

BACKGROUND AND OBJECTIVES: Since the launch of ChatGPT in 2023, large language models have attracted substantial interest to be deployed in the health care sector. This study evaluates the performance of ChatGPT-4o as a support tool for decision-making in multidisciplinary sarcoma tumor boards.

Authors

  • Tekoshin Ammo
    Department of Plastic Surgery, Hand and Reconstructive Surgery, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Vincent G J Guillaume
    Department of Plastic Surgery, Hand and Reconstructive Surgery, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Ulf Krister Hofmann
    Department of Orthopedics, Trauma and Reconstructive Surgery, Division of Arthroplasty, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Norma M Ulmer
    Department of Radiation Oncology, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Nina Buenting
    Department of Diagnostic and Interventional Radiology, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Florian Laenger
    Institute of Pathology, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Justus P Beier
    Department of Plastic Surgery, Hand and Reconstructive Surgery, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
  • Tim Leypold
    Department of Plastic Surgery, Hand and Reconstructive Surgery, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.

Keywords

No keywords available for this article.